A species of gram-positive, rod-shaped LACTIC ACID bacteria found naturally in the human intestinal flora and BREAST MILK.
A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Pathogenicity from this genus is rare.
Propane is a colorless, odorless, and chemically simple hydrocarbon (C3H8), commonly used as a fuel for heating, cooking, and engines, which exists as a gas at room temperature but can be liquefied under pressure and stored in cylinders or tanks.
Glyceraldehyde is a triose sugar, a simple monosaccharide (sugar) that contains three carbon atoms, with the molecular formula C3H6O3, and it exists in two structural forms, namely D-glyceraldehyde and L-glyceraldehyde, which are diastereomers of each other, and it is a key intermediate in several biochemical pathways, including glycolysis and gluconeogenesis.
Live microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. (J. Nutr. 1995;125:1401-12)
A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk.
A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina.
A species of rod-shaped, LACTIC ACID bacteria used in PROBIOTICS and SILAGE production.
A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation that is commonly seen in infants. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.
An endocellulase with specificity for the hydrolysis of 1,3- or 1,4-linkages in beta-D-glucans. This enzyme specifically acts on sites where reducing glucose residues are substituted at the 3 position.
A genus of gram-positive, anaerobic, cocci to short rod-shaped ARCHAEA, in the family METHANOBACTERIACEAE, order METHANOBACTERIALES. They are found in the GASTROINTESTINAL TRACT or other anoxic environments.
Cyclic TETRAPYRROLES based on the corrin skeleton.
A natural association between organisms that is detrimental to at least one of them. This often refers to the production of chemicals by one microorganism that is harmful to another.
A species of gram-positive, rod-shaped bacteria used in PROBIOTICS.
Polysaccharides composed of D-fructose units.
Agents used to prevent the formation of foam or to treat flatulence or bloat.
Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).
A family of gram-positive bacteria in the order Lactobacillales. Lactic acid is the main product of their carbohydrate metabolism.
Baked food product made of flour or meal that is moistened, kneaded, and sometimes fermented. A major food since prehistoric times, it has been made in various forms using a variety of ingredients and methods.
A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTIGALES. They contain polyflagellate zoospores and grow on a range of simple and complex carbohydrates in the rumen of sheep and cattle.
3-Acetyl-5-sec-butyl-4-hydroxy-3-pyrrolin-2-one. A metabolite found in a strain of the fungus Alternaria tenuis Auct. which functions as an antibiotic with antiviral and antineoplastic properties, and may also act as a mycotoxin.
A poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. It is used as an antiflatulent, surfactant, and ointment base.
A species of gram-positive, rod-shaped bacteria associated with DENTAL CARIES.
Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.
A species of gram-positive, rod-shaped LACTIC ACID bacteria that is frequently used as starter culture in SILAGE fermentation, sourdough, and lactic-acid-fermented types of beer and wine.
The viscous secretion of mucous membranes. It contains mucin, white blood cells, water, inorganic salts, and exfoliated cells.
Proteins found in any species of bacterium.

Expression of rumen microbial fibrolytic enzyme genes in probiotic Lactobacillus reuteri. (1/115)

This study was aimed at evaluating the cloning and expression of three rumen microbial fibrolytic enzyme genes in a strain of Lactobacillus reuteri and investigating the probiotic characteristics of these genetically modified lactobacilli. The Neocallimastix patriciarum xylanase gene xynCDBFV, the Fibrobacter succinogenes beta-glucanase (1,3-1,4-beta-D-glucan 4-glucanohydrolase [EC 3.2.1.73]) gene, and the Piromyces rhizinflata cellulase gene eglA were cloned in a strain of L. reuteri isolated from the gastrointestinal tract of broilers. The enzymes were expressed and secreted under the control of the Lactococcus lactis lacA promoter and its secretion signal. The L. reuteri transformed strains not only acquired the capacity to break down soluble carboxymethyl cellulose, beta-glucan, or xylan but also showed high adhesion efficiency to mucin and mucus and resistance to bile salt and acid.  (+info)

Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study. (2/115)

BACKGROUND: Short term illnesses, usually caused by respiratory or gastrointestinal diseases are disruptive to productivity and there is relatively little focus on preventative measures. This study examined the effect of the probiotic Lactobacillus reuteri protectis (ATCC55730) on its ability to improve work-place healthiness by reducing short term sick-leave caused by respiratory or gastrointestinal infections. METHODS: 262 employees at TetraPak in Sweden (day-workers and three-shift-workers) that were healthy at study start were randomised in a double-blind fashion to receive either a daily dose of 108 Colony Forming Units of L. reuteri or placebo for 80 days. The study products were administered with a drinking straw. 181 subjects complied with the study protocol, 94 were randomised to receive L. reuteri and 87 received placebo. RESULTS: In the placebo group 26.4% reported sick-leave for the defined causes during the study as compared with 10.6% in the L. reuteri group (p < 0.01). The frequency of sick-days was 0.9% in the placebo group and 0.4% in the L. reuteri group (p < 0.01). Among the 53 shift-workers, 33% in the placebo group reported sick during the study period as compared with none in the L. reuteri group(p < 0.005).  (+info)

Ecological behavior of Lactobacillus reuteri 100-23 is affected by mutation of the luxS gene. (3/115)

The luxS gene of Lactobacillus reuteri 100-23C was amplified by PCR, cloned, and then sequenced. To define a physiological and ecological role for the luxS gene in L. reuteri 100-23C, a luxS mutant was constructed by insertional mutagenesis. The luxS mutant did not produce autoinducers AI-2 or AI-3. Complementation of the luxS mutation by a plasmid construct containing luxS restored AI-2 and AI-3 synthesis. In vitro experiments revealed that neither the growth rate, nor the cell yield, nor cell survival in the stationary phase were compromised in the luxS mutant relative to the wild type and complemented mutant. The ATP content of exponentially growing cells of the luxS mutant was, however, 65% of that of wild-type cells. Biofilms formed by the luxS mutant on plastic surfaces in a bioreactor were thicker than those formed by the wild type. Biofilm thickness was not restored to wild-type values by the addition of purified AI-2 to the culture medium. In vivo experiments, conducted with ex-Lactobacillus-free mice, showed that biofilms formed by the mutant strain on the epithelial surface of the forestomach were approximately twice as thick as those formed by the wild type. The ecological performance of the luxS mutant, when in competition with L. reuteri strain 100-93 in the mouse cecum, was reduced compared to that of a xylA mutant of 100-23C. These results demonstrate that LuxS influences important ecological attributes of L. reuteri 100-23C, the consequences of which are niche specific.  (+info)

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. (4/115)

BACKGROUND AND AIMS: Probiotic bacteria are being investigated as possible treatments for many intestinal disorders. The present study aimed to explore the effects of live, heat killed, or gamma irradiated Lactobacillus reuteri on cardio-autonomic response and single fibre unit discharge in dorsal root ganglia to colorectal distension in healthy Sprague-Dawley rats housed under conventional conditions. The effects of this treatment on somatic pain were also examined. METHODS: 1x10(9) bacteria were given by gavage for nine days. Colorectal distension occurred under anaesthesia. Heart rate was measured through continuous electrocardiography. Single fibre unit discharge was recorded from the 6th left lumbar dorsal root ganglion. Somatic pain was evaluated by the tail flick and paw pressure tests. RESULTS: Colorectal distension caused a pressure dependent bradycardia in the control (native medium) group. Treatment with live, heat killed, or gamma irradiated bacteria as well as their products (conditioned medium) prevented the pain response even during the maximum distension pressure (80 mm Hg). Both viable and non-viable bacteria significantly decreased dorsal root ganglion single unit activity to distension. No effects on somatic pain were seen with any treatment. CONCLUSIONS: Oral administration of either live or killed probiotic bacteria or conditioned medium inhibited the constitutive cardio-autonomic response to colorectal distension in rats through effects on enteric nerves. These data may provide a novel explanation for beneficial probiotic effects on visceral pain.  (+info)

A Bacillus megaterium plasmid system for the production, export, and one-step purification of affinity-tagged heterologous levansucrase from growth medium. (5/115)

A multiple vector system for the production and export of recombinant affinity-tagged proteins in Bacillus megaterium was developed. Up to 1 mg/liter of a His6-tagged or Strep-tagged Lactobacillus reuteri levansucrase was directed into the growth medium, using the B. megaterium esterase LipA signal peptide, and recovered by one-step affinity chromatography.  (+info)

Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. (6/115)

Lactobacillus reuteri RC-14 has previously been shown to inhibit Staphylococcus aureus infection in a rat surgical-implant model. To investigate the basis for this, communication events between the two bacterial species were examined. L. reuteri RC-14 and Staph. aureus Newman were grown in a co-culture apparatus that physically separates the two species, while allowing the passage of soluble compounds. Using two-dimensional gel electrophoresis (2D-E), protein expression changes in Staph. aureus were analysed in response to co-culture with medium alone, L. reuteri RC-14, and a Lactobacillus strain that did not inhibit Staph. aureus infection in the rat model. It was observed that one protein in particular, identified as staphylococcal superantigen-like protein 11 (SSL11), showed a dramatic decrease in expression in response to growth with L. reuteri RC-14. Genetic reporters that placed both gfp and lux under the transcriptional control of the SSL11 promoter confirmed the 2D-E results. Interestingly, using similar reporter gene experiments, it was observed that the Staph. aureus P3 promoter from the staphylococcal accessory gene regulator (agr) locus also showed a decrease in expression in response to growth in the presence of L. reuteri RC-14. It was further demonstrated that L. reuteri RC-14 supernatant contained small unidentified molecules that were able to repress the SSL11 and P3 promoters, but the repression of SSL11 occurred independently of the agr system. These results suggest that L. reuteri RC-14 has the potential to alter the virulence of Staph. aureus via secretion of cell-cell signalling molecules.  (+info)

The levansucrase and inulosucrase enzymes of Lactobacillus reuteri 121 catalyse processive and non-processive transglycosylation reactions. (7/115)

Bacterial fructosyltransferase (FTF) enzymes synthesize fructan polymers from sucrose. FTFs catalyse two different reactions, depending on the nature of the acceptor, resulting in: (i) transglycosylation, when the growing fructan chain (polymerization), or mono- and oligosaccharides (oligosaccharide synthesis), are used as the acceptor substrate; (ii) hydrolysis, when water is used as the acceptor. Lactobacillus reuteri 121 levansucrase (Lev) and inulosucrase (Inu) enzymes are closely related at the amino acid sequence level (86 % similarity). Also, the eight amino acid residues known to be involved in catalysis and/or sucrose binding are completely conserved. Nevertheless, these enzymes differ markedly in their reaction and product specificities, i.e. in beta(2-->6)- versus beta(2-->1)-glycosidic-bond specificity (resulting in levan and inulin synthesis, respectively), and in the ratio of hydrolysis versus transglycosylation activities [resulting in glucose and fructooligosaccharides (FOSs)/polymer synthesis, respectively]. The authors report a detailed characterization of the transglycosylation reaction products synthesized by the Lb. reuteri 121 Lev and Inu enzymes from sucrose and related oligosaccharide substrates. Lev mainly converted sucrose into a large levan polymer (processive reaction), whereas Inu synthesized mainly a broad range of FOSs of the inulin type (non-processive reaction). Interestingly, the two FTF enzymes were also able to utilize various inulin-type FOSs (1-kestose, 1,1-nystose and 1,1,1-kestopentaose) as substrates, catalysing a disproportionation reaction; to the best of our knowledge, this has not been reported for bacterial FTF enzymes. Based on these data, a model is proposed for the organization of the sugar-binding subsites in the two Lb. reuteri 121 FTF enzymes. This model also explains the catalytic mechanism of the enzymes, and differences in their product specificities.  (+info)

Construction and characterization of nisin-controlled expression vectors for use in Lactobacillus reuteri. (8/115)

The Nisin-controlled gene expression (NICE) system, which was discovered in Lactococcus lactis, was adapted to Lactobacillus reuteri by ligating nisA promoter (PnisA) and nisRK DNA fragments into the Escherichia coli-Lb. reuteri shuttle vector pSTE32. This chimerical plasmid (pNICE) was capable of expressing the heterologous amylase gene (amyL) under nisin induction. Optimization of induction factors for this Lb. reuteri/pNICE system, including nisin concentration (viz. 50 ng/ml), growth phase of culture at which nisin be added (viz. at the early exponential phase), and the best time for analyzing the gene product after inoculation (viz. at the 3rd h), allowed the amylase product to be expressed in high amounts, constituting up to about 18% of the total intracellular protein. Furthermore, the signal peptide (SP) of amyL gene (SPamyL) from Bacillus licheniformis was ligated to the downstream of PnisA in pNICE, upgrading this vector to a NICE-secretion (NIES) level, which was then designated pNIES (Sec+, secretion positive). Characterization of pNIES using an amyL-SPDelta gene (amyL gene lacking its SP) as a reporter revealed the 3rd h after induction as the secretion peak of this system, at which the secretion efficiency and the amount of alpha-amylase being secreted into the culture supernatant were estimated to reach 77.6% and 27.75 mg/l. Expression and secretion of AmyL products by pNIES in Lb. reuteri was also confirmed by SDS-PAGE and immunoblotting analysis.  (+info)

Lactobacillus reuteri is a species of gram-positive, facultatively anaerobic bacteria that belongs to the lactic acid bacteria group. It is commonly found in the gastrointestinal tract of humans and other animals, as well as in some fermented foods.

Lactobacillus reuteri has been studied for its potential probiotic benefits, including its ability to inhibit the growth of harmful bacteria, stimulate the immune system, and promote digestive health. It produces several antimicrobial compounds, such as lactic acid, reuterin, and bacteriocins, which help maintain a healthy balance of microorganisms in the gut.

Lactobacillus reuteri has also been shown to have anti-inflammatory effects, which may be beneficial in treating conditions such as inflammatory bowel disease, irritable bowel syndrome, and eczema. Additionally, it may help prevent dental cavities by inhibiting the growth of harmful oral bacteria.

It's worth noting that while Lactobacillus reuteri has shown promise in various studies, more research is needed to fully understand its potential health benefits and safety.

Lactobacillus is a genus of gram-positive, rod-shaped, facultatively anaerobic or microaerophilic, non-spore-forming bacteria. They are part of the normal flora found in the intestinal, urinary, and genital tracts of humans and other animals. Lactobacilli are also commonly found in some fermented foods, such as yogurt, sauerkraut, and sourdough bread.

Lactobacilli are known for their ability to produce lactic acid through the fermentation of sugars, which contributes to their role in maintaining a healthy microbiota and lowering the pH in various environments. Some species of Lactobacillus have been shown to provide health benefits, such as improving digestion, enhancing immune function, and preventing infections, particularly in the urogenital and intestinal tracts. They are often used as probiotics, either in food or supplement form, to promote a balanced microbiome and support overall health.

I'm sorry for any confusion, but "Propane" is not a medical term. It is a chemical compound commonly used as a fuel for heating, cooking, and engines. Propane is a gas at room temperature and pressure, but it can be liquefied under moderate pressure and stored in cylinders or tanks.

If you have any questions about a medical term or concept, I'd be happy to try to help answer those for you!

Glyceraldehyde is a triose, a simple sugar consisting of three carbon atoms. It is a clear, colorless, sweet-tasting liquid that is used as a sweetener and preservative in the food industry. In the medical field, glyceraldehyde is used in research and diagnostics, particularly in the study of carbohydrate metabolism and enzyme function.

Glyceraldehyde is also an important intermediate in the glycolytic pathway, which is a series of reactions that convert glucose into pyruvate, producing ATP and NADH as energy-rich compounds. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is an enzyme that catalyzes the conversion of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate in this pathway.

In addition, glyceraldehyde has been studied for its potential role in the development of diabetic complications and other diseases associated with carbohydrate metabolism disorders.

Probiotics are defined by the World Health Organization (WHO) as "live microorganisms which when administered in adequate amounts confer a health benefit on the host." They are often referred to as "good" or "friendly" bacteria because they help keep your gut healthy. Probiotics are naturally found in certain foods such as fermented foods like yogurt, sauerkraut, and some cheeses, or they can be taken as dietary supplements.

The most common groups of probiotics are lactic acid bacteria (like Lactobacillus) and bifidobacteria. They can help restore the balance of bacteria in your gut when it's been disrupted by things like illness, medication (such as antibiotics), or poor diet. Probiotics have been studied for their potential benefits in a variety of health conditions, including digestive issues, skin conditions, and even mental health disorders, although more research is needed to fully understand their effects and optimal uses.

Lactobacillus acidophilus is a species of gram-positive, rod-shaped bacteria that naturally occurs in the human body, particularly in the mouth, intestines, and vagina. It is a type of lactic acid bacterium (LAB) that converts sugars into lactic acid as part of its metabolic process.

In the intestines, Lactobacillus acidophilus helps maintain a healthy balance of gut flora by producing bacteriocins, which are natural antibiotics that inhibit the growth of harmful bacteria. It also helps in the digestion and absorption of food, produces vitamins (such as vitamin K and some B vitamins), and supports the immune system.

Lactobacillus acidophilus is commonly used as a probiotic supplement to help restore or maintain a healthy balance of gut bacteria, particularly after taking antibiotics or in cases of gastrointestinal disturbances. It can be found in fermented foods such as yogurt, kefir, sauerkraut, and some cheeses.

It's important to note that while Lactobacillus acidophilus has many potential health benefits, it should not be used as a substitute for medical treatment or advice from a healthcare professional.

Lactobacillus casei is a species of Gram-positive, rod-shaped bacteria that belongs to the genus Lactobacillus. These bacteria are commonly found in various environments, including the human gastrointestinal tract, and are often used in food production, such as in the fermentation of dairy products like cheese and yogurt.

Lactobacillus casei is known for its ability to produce lactic acid, which gives it the name "lactic acid bacterium." This characteristic makes it an important player in maintaining a healthy gut microbiome, as it helps to lower the pH of the gut and inhibit the growth of harmful bacteria.

In addition to its role in food production and gut health, Lactobacillus casei has been studied for its potential probiotic benefits. Probiotics are live bacteria and yeasts that are beneficial to human health, particularly the digestive system. Some research suggests that Lactobacillus casei may help support the immune system, improve digestion, and alleviate symptoms of certain gastrointestinal disorders like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). However, more research is needed to fully understand its potential health benefits and applications.

Lactobacillus plantarum is a species of gram-positive, rod-shaped bacteria that belongs to the lactic acid bacteria group. It is a facultative anaerobe, meaning it can grow in the presence or absence of oxygen. Lactobacillus plantarum is commonly found in a variety of environments, including fermented foods such as sauerkraut, kimchi, and sourdough bread, as well as in the gastrointestinal tract of humans and other animals.

Lactobacillus plantarum is known for its ability to produce lactic acid through the fermentation of carbohydrates, which can help to preserve food and inhibit the growth of harmful bacteria. It also produces various antimicrobial compounds that can help to protect against pathogens in the gut.

In addition to its use in food preservation and fermentation, Lactobacillus plantarum has been studied for its potential probiotic benefits. Probiotics are live bacteria and yeasts that are believed to provide health benefits when consumed, including improving digestive health, enhancing the immune system, and reducing the risk of certain diseases.

Research has suggested that Lactobacillus plantarum may have a range of potential health benefits, including:

* Improving gut barrier function and reducing inflammation in the gut
* Enhancing the immune system and reducing the risk of infections
* Alleviating symptoms of irritable bowel syndrome (IBS) and other gastrointestinal disorders
* Reducing the risk of allergies and asthma
* Improving oral health by reducing plaque and preventing tooth decay

However, more research is needed to fully understand the potential health benefits of Lactobacillus plantarum and to determine its safety and effectiveness as a probiotic supplement.

Colic is a term used to describe excessive, frequent crying or fussiness in a healthy infant, often lasting several hours a day and occurring several days a week. Although the exact cause of colic is unknown, it may be related to digestive issues, such as gas or indigestion. The medical community defines colic by the "Rule of Three": crying for more than three hours per day, for more than three days per week, and for longer than three weeks in an infant who is well-fed and otherwise healthy. It typically begins within the first few weeks of life and improves on its own, usually by age 3-4 months. While colic can be distressing for parents and caregivers, it does not cause any long-term harm to the child.

Methanobrevibacter is a genus of archaea (single-celled microorganisms) that are methanogens, meaning they produce methane as a metabolic byproduct. These organisms are commonly found in the digestive tracts of animals, including humans, where they help break down organic matter and recycle nutrients. They are strict anaerobes, requiring an environment free of oxygen to survive and grow. Some species within this genus have been associated with dental diseases such as periodontitis. However, more research is needed to fully understand their role in human health and disease.

Corrinoids are a class of compounds that include vitamin B12 and its analogs. Vitamin B12 is an essential nutrient for humans and other animals, playing a critical role in the synthesis of DNA, the maintenance of the nervous system, and the metabolism of fatty acids and amino acids.

The corrinoid ring is the structural backbone of vitamin B12 and its analogs. It is a complex, planar molecule made up of four pyrrole rings joined together in a macrocycle. The corrinoid ring contains a central cobalt ion, which can form coordination bonds with various ligands, including organic groups such as methyl, hydroxo, and cyano.

Corrinoids can be found in a wide variety of foods, including meat, dairy products, fish, eggs, and some fortified plant-based foods. They are also produced by certain bacteria, which can synthesize the corrinoid ring and the cobalt ion de novo. Some corrinoids have biological activity similar to vitamin B12, while others do not.

In addition to their role in human nutrition, corrinoids are also used in industrial applications, such as the production of antibiotics and other pharmaceuticals. They are also used as catalysts in chemical reactions, due to their ability to form stable coordination complexes with various ligands.

Antibiosis is a type of interaction between different organisms in which one organism, known as the antibiotic producer, produces a chemical substance (known as an antibiotic) that inhibits or kills another organism, called the susceptible organism. This phenomenon was first discovered in bacteria and fungi, where certain species produce antibiotics to inhibit the growth of competing species in their environment.

The term "antibiosis" is derived from Greek words "anti" meaning against, and "biosis" meaning living together. It is a natural form of competition that helps maintain the balance of microbial communities in various environments, such as soil, water, and the human body.

In medical contexts, antibiosis refers to the use of antibiotics to treat or prevent bacterial infections in humans and animals. Antibiotics are chemical substances produced by microorganisms or synthesized artificially that can inhibit or kill other microorganisms. The discovery and development of antibiotics have revolutionized modern medicine, saving countless lives from bacterial infections that were once fatal.

However, the overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, which can no longer be killed or inhibited by conventional antibiotics. Antibiotic resistance is a significant global health concern that requires urgent attention and action from healthcare providers, policymakers, and the public.

Lactobacillus rhamnosus is a species of gram-positive, facultatively anaerobic bacteria that belongs to the genus Lactobacillus. It is a rod-shaped bacterium that is commonly found in the human gastrointestinal tract and is also present in some fermented foods like yogurt and cheese.

L. rhamnosus is known for its ability to produce lactic acid, which helps maintain a healthy balance of microflora in the gut and inhibit the growth of harmful bacteria. It has been studied for its potential probiotic benefits, including improving digestive health, enhancing immune function, and alleviating symptoms of certain gastrointestinal disorders like irritable bowel syndrome and inflammatory bowel disease.

L. rhamnosus is also known to adhere well to the intestinal epithelium, which allows it to persist in the gut for longer periods compared to other lactobacilli species. This property has made it a popular strain for use in various probiotic supplements and functional foods. However, it is important to note that while L. rhamnosus has shown promise in several clinical studies, more research is needed to fully understand its potential health benefits and safety profile.

Fructans are a type of carbohydrate known as oligosaccharides, which are made up of chains of fructose molecules. They are found in various plants, including wheat, onions, garlic, and artichokes. Some people may have difficulty digesting fructans due to a lack of the enzyme needed to break them down, leading to symptoms such as bloating, diarrhea, and stomach pain. This condition is known as fructan intolerance or fructose malabsorption. Fructans are also considered a type of FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols), which are short-chain carbohydrates that can be poorly absorbed by the body and may cause digestive symptoms in some individuals.

Antifoaming agents are substances that prevent or reduce the formation of foam in liquids. They are often used in industrial processes, such as manufacturing and food production, to minimize the negative effects of foam on equipment performance, product quality, and safety. In a medical context, antifoaming agents may be used in certain medications, intravenous (IV) fluids, or enteral feedings to prevent or treat foaming that can interfere with proper administration or absorption of the treatment.

These agents work by reducing surface tension, promoting bubble rupture, or absorbing excess gases. Common antifoaming agents include silicone-based compounds, such as dimethicone and simethicone, as well as other substances like polyoxyethylene sorbitan monostearate (Tween) and alcohols.

In some cases, antifoaming agents may be used during medical procedures to prevent or treat the accumulation of foam in body cavities, such as the stomach or lungs. For instance, simethicone is sometimes administered to newborns with meconium ileus (a bowel obstruction caused by thickened meconium) to help reduce the formation of gas and facilitate the passage of meconium. Similarly, antifoaming agents may be used in mechanical ventilation to prevent or treat pulmonary air leaks and improve oxygenation.

While antifoaming agents are generally considered safe when used as directed, they can have side effects, particularly if overused or misused. Potential adverse reactions include gastrointestinal symptoms like diarrhea, nausea, or bloating, as well as allergic reactions in sensitive individuals. It is essential to follow the recommended dosage and administration guidelines provided by a healthcare professional when using antifoaming agents for medical purposes.

The gastrointestinal (GI) tract, also known as the digestive tract, is a continuous tube that starts at the mouth and ends at the anus. It is responsible for ingesting, digesting, absorbing, and excreting food and waste materials. The GI tract includes the mouth, esophagus, stomach, small intestine (duodenum, jejunum, ileum), large intestine (cecum, colon, rectum, anus), and accessory organs such as the liver, gallbladder, and pancreas. The primary function of this system is to process and extract nutrients from food while also protecting the body from harmful substances, pathogens, and toxins.

Leuconostocaceae is a family of gram-positive, facultatively anaerobic bacteria within the order Lactobacillales. These bacteria are non-motile, non-spore forming, and often occur in pairs or chains. They are commonly found in a variety of environments including plants, dairy products, and the human gastrointestinal tract. Some species of Leuconostocaceae can cause disease in humans, particularly in immunocompromised individuals. They are known to be involved in food fermentation and are often used in the production of various fermented foods such as sauerkraut, pickles, and certain dairy products.

I apologize, but "bread" is a common food item and not a medical term. It is typically made from flour, water, yeast, and salt, and is baked at high temperatures. There is no medical definition for bread. If you have any specific concerns about bread or its ingredients in relation to your health, I would be happy to try to help address those.

Neocallimastix is a genus of anaerobic fungi that are commonly found in the digestive tracts of herbivorous mammals and birds, where they play a crucial role in breaking down complex plant material into simpler compounds that can be absorbed and utilized by their hosts. These fungi are characterized by their ability to produce enzymes that can break down cellulose, hemicellulose, and lignin, the major structural components of plant cell walls. Under a microscope, Neocallimastix species appear as branching, septate hyphae with rounded or pointed ends, and they reproduce by forming spores within specialized structures called sporangia.

Tenuazonic acid is a mycotoxin, which is a toxic compound produced by certain types of fungi. It is primarily produced by the fungus Alternaria spp., and can be found in various food sources such as grains, vegetables, and fruits that have been contaminated with this fungus.

Tenuazonic acid has been reported to have several toxic effects, including neurotoxicity, immunotoxicity, and genotoxicity. It has also been shown to inhibit protein synthesis in both prokaryotic and eukaryotic cells, which can lead to cell death. Exposure to tenuazonic acid can occur through the ingestion of contaminated food or inhalation of contaminated air.

It is important to note that exposure to high levels of tenuazonic acid can be harmful to human health, and regulatory bodies have set limits on the allowable levels of this mycotoxin in food and feed. However, further research is needed to fully understand the potential health risks associated with exposure to tenuazonic acid.

Simethicone is an anti-foaming agent that is commonly used in the medical field, particularly for the treatment of gastric symptoms such as bloating and discomfort caused by excessive gas in the gastrointestinal tract. It works by reducing the surface tension of gas bubbles in the stomach and intestines, allowing them to combine and be expelled more easily from the body.

Simethicone is not absorbed into the bloodstream and has minimal systemic absorption, making it a safe and well-tolerated medication for most individuals. It can be found in various forms, including tablets, chewable tablets, capsules, and liquids, and is often combined with other medications to provide symptomatic relief of gastric discomfort.

It's important to note that simethicone should only be used as directed by a healthcare professional, and individuals should always consult their doctor or pharmacist before taking any new medication.

Lactobacillus fermentum is a species of gram-positive, facultatively anaerobic, rod-shaped bacteria that belongs to the lactic acid bacteria group. It is commonly found in various environments such as plant material, dairy products, and the human gastrointestinal tract.

Lactobacillus fermentum is known for its ability to produce lactic acid through the fermentation of carbohydrates, which can help lower the pH of the environment and inhibit the growth of harmful bacteria. It also produces various antimicrobial compounds such as bacteriocins, which can further contribute to its probiotic properties.

Lactobacillus fermentum has been studied for its potential health benefits, including its ability to enhance immune function, improve gut health, and reduce symptoms of gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). It is also being investigated for its potential role in preventing urogenital infections and reducing the risk of certain types of cancer.

However, it's important to note that while some studies suggest potential health benefits of Lactobacillus fermentum, more research is needed to fully understand its effects and safety profile. As with any probiotic supplement, it's recommended to consult with a healthcare provider before taking Lactobacillus fermentum or any other probiotics.

Fermentation is a metabolic process in which an organism converts carbohydrates into alcohol or organic acids using enzymes. In the absence of oxygen, certain bacteria, yeasts, and fungi convert sugars into carbon dioxide, hydrogen, and various end products, such as alcohol, lactic acid, or acetic acid. This process is commonly used in food production, such as in making bread, wine, and beer, as well as in industrial applications for the production of biofuels and chemicals.

Lactobacillus brevis is a species of gram-positive, rod-shaped, facultatively anaerobic bacteria that belongs to the lactic acid bacteria group. It is commonly found in various environments such as plants, soil, and fermented foods like sauerkraut, pickles, and sourdough bread. Lactobacillus brevis is also part of the normal microbiota of the human gastrointestinal tract and vagina.

This bacterium is known for its ability to produce lactic acid as a metabolic end-product, which contributes to the preservation and fermentation of food. Lactobacillus brevis can also produce other compounds with potential health benefits, such as bacteriocins, which have antibacterial properties against certain pathogenic bacteria.

In some cases, Lactobacillus brevis has been investigated for its probiotic potential, although more research is needed to fully understand its effects on human health. It's important to note that while some strains of Lactobacillus brevis may have beneficial properties, others can cause infections in individuals with weakened immune systems or underlying medical conditions.

Mucus is a viscous, slippery secretion produced by the mucous membranes that line various body cavities such as the respiratory and gastrointestinal tracts. It serves to lubricate and protect these surfaces from damage, infection, and foreign particles. Mucus contains water, proteins, salts, and other substances, including antibodies, enzymes, and glycoproteins called mucins that give it its characteristic gel-like consistency.

In the respiratory system, mucus traps inhaled particles such as dust, allergens, and pathogens, preventing them from reaching the lungs. The cilia, tiny hair-like structures lining the airways, move the mucus upward toward the throat, where it can be swallowed or expelled through coughing or sneezing. In the gastrointestinal tract, mucus helps protect the lining of the stomach and intestines from digestive enzymes and other harmful substances.

Excessive production of mucus can occur in various medical conditions such as allergies, respiratory infections, chronic lung diseases, and gastrointestinal disorders, leading to symptoms such as coughing, wheezing, nasal congestion, and diarrhea.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

... and Lactobacillus reuteri. Bacteria which give negative results for the indole test include: Actinobacillus spp., Aeromonas ...
Joint Genome Institute on L. reuteri Savino F, Pelle E, Palumeri E, Oggero R, Miniero R (January 2007). "Lactobacillus reuteri ... Kandler O.; Stetter K.; Kohl R. (1980). "Lactobacillus reuteri sp. nov. a new species of heterofermentative lactobacilli". ZBL ... June 2008). "Comparative genome analysis of Lactobacillus reuteri and Lactobacillus fermentum reveal a genomic island for ... Sinkiewicz G, Nordström EA (2005). "Occurrence of Lactobacillus reuteri, lactobacilli and bifidobacteria in human breast milk ...
Ivan believed that Lactobacillus reuteri is one of the bacteria that a mother should transfer to her offspring, whether a ... reuteri strain and oral health products containing L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC ... It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. ... Vivekananda, MR; Vandana, KL; Bhat, KG (2010). "Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of ...
Oh JH, van Pijkeren JP (2014-09-29). "CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri". Nucleic Acids Research. 42 ...
The use of probiotics, specifically Lactobacillus reuteri, decreases crying time at three weeks by 46 minutes in breastfeed ... "Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis". Pediatrics. 141 (1): e20171811. doi:10.1542/peds.2017-1811. PMID ...
El-Ziney MG, van den Tempel T, Debevere J, Jakobsen M (March 1999). "Application of reuterin produced by Lactobacillus reuteri ... Stevens M, Vollenweider S, Lacroix C (2011). "The potential of reuterin produced by Lactobacillus reuteri as a broad spectrum ... The name reuterin is derived from Lactobacillus reuteri, which produces the compound biosynthetically from glycerol as a broad- ... Reuterin is a potent antimicrobial compound produced by Lactobacillus reuteri. It is an intermediate in the metabolism of ...
Casas, Ivan A.; Dobrogosz, Walter J. (December 1, 2000). "Validation of the Probiotic Concept: Lactobacillus reuteri Confers ... best known for his discovery and further research on the probiotic bacterium Lactobacillus reuteri. Dobrogosz was born on ... "Principles of ex ovo competitive exclusion and in ovo administration of Lactobacillus reuteri". Poult. Sci. 76 (1): 179-96. doi ... a growth inhibitor produced by Lactobacillus reuteri". Antimicrob. Agents Chemother. 32 (12): 1854-8. doi:10.1128/aac.32.12. ...
August 2017). "Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells". Science. 357 (6353): 806-810. doi:10.1126 ... AhR is activated by indole metabolites of tryptophan induced by microbiota, such as Lactobacillus reuteri. Therefore, the DP ...
For example, Limosilactobacillus reuteri (formerly Lactobacillus reuteri) can inhibit the growth of many different bacterial ... 2014 "Lactobacillus backi" Bohak et al. 2006 Lactobacillus bombicola Praet et al. 2015 Lactobacillus colini Zhang et al. 2017 ... 2018 Lactobacillus pasteurii Cousin et al. 2013 Lactobacillus porci Kim et al. 2018 Lactobacillus psittaci Lawson et al. 2001 " ... Data related to Lactobacillus at Wikispecies Lactobacillus at Milk the Funk Wiki Lactobacillus at BacDive - the Bacterial ...
... reuteri has been used as a model organism to evaluate the host-adaptation of lactobacilli to the human and ... Zheng, Jinshui; Zhao, Xin; Lin, Xiaoxi B.; Gänzle, Michael (2015-12-11). "Comparative genomics Lactobacillus reuteri from ... "The Evolution of Host Specialization in the Vertebrate Gut Symbiont Lactobacillus reuteri". PLOS Genetics. 7 (2): e1001314. doi ... "Experimental Evaluation of Host Adaptation of Lactobacillus reuteri to Different Vertebrate Species". Applied and Environmental ...
"High-Level Folate Production in Fermented Foods by the B12 Producer Lactobacillus reuteri JCM1112". Applied and Environmental ... Silage inoculants contain one or more strains of lactic acid bacteria, and the most common is Lactobacillus plantarum. Other ... lactobacillus species produce folic acid and vitamin B12. The fermentation process that produces VFA also yields energy that ... bacteria used include Lactobacillus buchneri, Enterococcus faecium and Pediococcus species. Ryegrasses have high sugars and ...
BMJ 2013;346:f3092 Sung V, … Wake M. Treating infant colic with the probiotic Lactobacillus reuteri: Double blind, placebo ... "Treating infant colic with the probiotic Lactobacillus reuteri: Double blind, placebo controlled randomised trial". BMJ ( ...
"Lactobacillus reuteri sp. nov., a New Species of Heterofermentative Lactobacilli". Zentralblatt für Bakteriologie: I. Abt. ... "Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but Not L. rhamnosus GG in the Human Vagina as ... "A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus ... Some strains of lactobacilli formerly mistakenly classified as L. fermentum (such as RC-14) have since been reclassified as ...
... mucosae and the related Lactobacillus reuteri. There are over 60 lactobacilli species known, many of which have been isolated ... Examples of other lactobacilli isolated from pig intestines include L. fermentum, L. acidophilus, and L. reuteri. ... Roos, Stefan; Hans Jonsson (February 2002). "A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres ... reuteri. Strain S32T was found to be identical to S14, and used to determine similarity rank among other lactobacilli. Using ...
December 2020). "Glyceraldehyde-3-Phosphate Dehydrogenase Increases the Adhesion of Lactobacillus reuteri to Host Mucin to ... Patel D. et al., showed that Lactobacillus acidophilus GAPDH binds with mucin, acting in adhesion. GAPDH can itself activate ... Ramiah K, van Reenen CA, Dicks LM (1 July 2008). "Surface-bound proteins of Lactobacillus plantarum 423 that contribute to ... June 2008). "Cell surface Lactobacillus plantarum LA 318 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) adheres to human ...
Lactobacillus reuteri in infants and Lactobacillus casei and Bifidobacterium breve in children have been found to be effective ... Mar 2013). "Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and ... Lactobacillus plantarum, in adults has been found to increase defecation frequency. Benzamide Cisapride Domperidone Itopride ... A further study found that in rats supplemented with a diet of Lactobacillus rhamnosus and Bifidobacterium lactis, the number ...
... a bacteriocin with lytic activity produced by Lactobacillus reuteri LA6". International Journal of Food Microbiology. 34 (2): ... Bacteriocins are made by non-pathogenic Lactobacilli in the vagina and help maintain the stability of the vaginal microbiome. ... and bacteriocin from Lactobacillus delbrueckii against influenza virus. As of 2009, some bacteriocins, cytolysin, pyocin S2, ... a circular bacteriocin produced by lactic acid bacteria Lactobacillus gasseri". World Journal of Microbiology & Biotechnology. ...
Lactobacillus rhamnosus, Lactobacillus reuteri, and Faecalibacterium prausnitzii have also been shown to significantly reduce ...
... contains live cultures (Lactobacillus reuteri), grain lactic acid, minerals and vitamins (though not in noteworthy ...
... is a bacteriocin produced by the bacterium Lactobacillus reuteri that has potential use as a food preservative. ...
... metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: ... The vaginal flora consists of those organisms which generally do not cause symptoms and is dominated mainly by Lactobacillus ... Petrova, Mariya I.; Lievens, Elke; Malik, Shweta; Imholz, Nicole; Lebeer, Sarah (2015). "Lactobacillus species as biomarkers ...
Probiotic Lactobacillus reuteri DSM 17938 in the Treatment of Rotaviral Gastroenteritis in Infants and Toddlers, a Randomized ...
Lactobacillus reuteri, Staphylococcus aureus, among others. Numerous natural and synthetic 2,5-DKPs are bioactive. These small ...
... best known for his discovery and further research on the probiotic bacterium Lactobacillus reuteri Paul M. Doty, former ...
Walter Dobrogosz (born 1933), American microbiologist, discoverer of Lactobacillus reuteri Theodosius Dobzhansky (1900-1975), ...
... and Lactobacillus reuteri are different strains of bacteria that are found to adhere to the gastrointestinal tract's mucosal ... pylori Moraxella catarrhalis Bordetella pertussis 987P-fimbriated enterotoxigenic Escherichia coli Lactobacillus reuteri ( ...
Lactobacillus fermentum Lactobacillus johnsonii Lactobacillus paracasei Lactobacillus plantarum Lactobacillus reuteri ... Enterococcus faecalis Lactobacillus acidophilus Lactobacillus brevis Lactobacillus bulgaricus Lactobacillus casei Lactobacillus ... Ting, W.J., et al., Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet ... Liao, P.H., et al., Heat-killed Lactobacillus Reuteri GMNL-263 Prevents Epididymal Fat Accumulation and Cardiac Injury in High- ...
Lactobacillus paralimentarius Lactobacillus pastorianus Lactobacillus plantarum Lactobacillus pontis Lactobacillus reuteri ... Lactobacillus brevis Lactobacillus buchneri Lactobacillus casei Lactobacillus crustorum Lactobacillus delbrueckii Lactobacillus ... farciminis Lactobacillus fermenti Lactobacillus fermentum Lactobacillus fructivorans Lactobacillus frumenti Lactobacillus ... Pichia saitoi Saccharomyces cerevisiae Torulopsis holmii Lactobacillus acetotolerans Lactobacillus acidophilus Lactobacillus ...
... reuteri. The further ingredients are formaldehyde and sodium ethylmercuric thiosalicylate (Thiomersal) as preservatives and ... described lactobacillus vaccination as a means to systemically boost a diminished pool of lactobacillus-specific vaginal ... The incidence of aberrant lactobacilli fell from 17% to 3%, while that of normal lactobacilli rose from 31% to 72% during the ... It has not been clarified by what mechanism the lactobacilli used in the vaccines ("aberrant" lactobacilli) fail to confer ...
Along with L. gallinarum, L. acidophilus, L. salivarius, L. fermentum, and L. reuteri, are found in high abundance in the ileum ... Lactobacillus crispatus, Lactobacillus amylovorus, Lactobacillus gallinarum, Lactobacillus gasseri, and Lactobacillus johnsonii ... with recognition of Lactobacillus gallinarum sp. nov. and Lactobacillus johnsonii sp. nov. and synonymy of Lactobacillus ... with recognition of Lactobacillus gallinarum sp. nov. and Lactobacillus johnsonii sp. nov. and synonymy of Lactobacillus ...
... J ... We fed 10(9)Lactobacillus reuteri (LR) or vehicle control to rats for 9 days. LR ingestion increased excitability (threshold ...
We performed a systematic review to update evidence on L. reuteri for treating AGE in children. We searched MEDLINE, EMBASE, ... Compared with placebo or no treatment, L. reuteri reduced diarrhea duration (four RCTs, n = 347, mean difference, MD −0.87 days ... 95% CI [−1.43, −0.31]). L. reuteri use was also associated with a reduced duration of hospitalization (three RCTs, n = 284, MD ... reuteri) for the management of acute gastroenteritis (AGE) has been recently questioned. ...
In this study, diversity of alcohol dehydrogenases in Lactobacillus species was investigated with a focus on L. reuteri. Nine ... L. reuteri mutants were generated in which the three ADHs were deleted individually. The lagging growth phenotype of these ... Since L. reuteri excretes high amounts of 3-HPA outside the microcompartment, the organism is likely to have alternative ... ADH enzymes were found in L. reuteri DSM20016, out of which 3 (PduQ, ADH6 and ADH7) belong to the group of iron-dependent ...
Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics 2014;133:e904-9.. OpenUrl ... Lactobacillus reuteri is an effective option for the prevention of diarrhoea in preschool children but may not be cost- ... Lactobacillus reuteri is an effective option for the prevention of diarrhoea in preschool children but may not be cost- ... The probiotics and placebo arms were identical, except for the presence of the probiotic Lactobacillus reuteri, given daily ...
Since L. reuteri excretes high amounts of 3-HPA... (More). Lactobacillus reuteri, a heterofermentative bacterium, metabolizes ... Redox balance in Lactobacillus reuteri DSM20016 : Roles of iron-dependent alcohol dehydrogenases in glucose/glycerol metabolism ... In this study, diversity of alcohol dehydrogenases in Lactobacillus species was investigated with a focus on L. reuteri. Nine ... In this study, diversity of alcohol dehydrogenases in Lactobacillus species was investigated with a focus on L. reuteri. Nine ...
... we aim to identify whether the probiotic Lactobacillus reuteri DSM 17938 is effective in the management of infant colic, and to ... Through an individual participant data meta-analysis (IPDMA), we aim to identify whether the probiotic Lactobacillus reuteri ...
Find out more about the probiotic strain Lactobacillus reuteri Protectis®, on the Probiotics Database. ... Lactobacillus reuteri strains: Lactobacillus reuteri RC-14®.. Lactobacillus rhamnosus strains: Lactobacillus rhamnosus LGG®, ... Lactobacillus reuteri Protectis® under the microscope. The Protectis® strain is a member of the Lactobacillus reuteri species; ... Lactobacillus casei strains: Lactobacillus casei Shirota, Lactobacillus casei DN-114001.. Lactobacillus plantarum strains: ...
Legal disclaimer Remember that everything on this website is intended for informational purposes only. The information on this site does not constitute medical advice. You should never, ever neglect to get medical care or try to self-diagnose or treat. All information on this site is intended to be used while under the supervision of a competent physician. For more about how harmful it can be to self-diagnose, check out this post: The Dangers of Doctor Google. Click here to view the entire Terms of Use and Privacy Policy.. ...
Our Lactobacillus Reuteri NCIMB 30242 probiotic supplement is among the few supplements clinically proven to support digestive ... Decrease quantity for Lactobacillus Reuteri NCIMB 30242 , Microbiome Plus+ Increase quantity for Lactobacillus Reuteri NCIMB ... Lactobacillus reuteri NCIMB 30242 Heart Health Probiotic * Gastrointestinal Combo Probiotic & Prebiotic Fiber L.reuteri NCIMB ... The oral supplement, lactobacillus reuteri NCIMB 30242, is an award-winning, heart-healthy probiotic. L reuteri is clinically ...
Spectrumceuticals Unit 8/5 Narabang Way, Belrose, NSW, Australia ...
Here are the top 5 benefits of lactobacillus reuteri probiotic. ... Lactobacillus reuteri, or L. reuteri for short, is one of the ... Reuteri itself is categorized into smaller sub-strains. The L. reuteri strain Primadophilus reuteri, for instance, supports ... What Are Some Lactobacillus Reuteri Benefits?. Probiotics in general are known for digestive health. But what are some specific ... Lactobacillus reuteri is one of the more potent bacterias that you want in your diet or through supplementation. ...
Lactobacillus reuteri strains: Lactobacillus reuteri Protectis and Lactobacillus reuteri RC-14 ®. Lactobacillus rhamnosus ... Our probiotic culture (Lactobacillus reuteri Protectis) is grown using a barley Lactobacillus reuteri Protectis är en ... Lactobacillus reuteri DSM 17938). Kosttillskott md mjölksyrabakterien Lactobacillus reuteri Protectis DSM 17938 och vitamin D3 ... kurio sudėtyje yra Lactobacillus reuteri Protectis® bakterijų ir vitamino D3. Lactobacillus reuteri Protectis® yra kompanijos „ ...
Check our review of the best probiotic supplements with Lactobacillus reuteri and learn how this probiotic strain can boost ... Whats the Best Lactobacillus Reuteri Supplement?. In this article, Ill review the best Lactobacillus supplements. Ill also ... What are the Health Benefits of Lactobacillus Reuteri?. *It reduces inflammation, so it can be very effective in treating and ... Lactobacillus reuteri is a probiotic strain that has been scientifically proved to boost your health protecting you from ...
Look for a supplement that contains Lactobacillus rhamnosus, Lactobacillus acidophilus, or Lactobacillus reuteri. ... Lactobacillus reuteri. This strain is effective in treating BV and yeast infections. It can also help prevent UTIs. ... Lactobacillus rhamnosus. This is one of the most effective strains for vaginal health. It can help prevent and treat BV, yeast ... Lactobacillus acidophilus. This is another common strain of probiotic. It can help prevent UTIs, yeast infections, BV, and ...
name=T-box(Pro) regulon. species= Lactobacillus reuteri JCM 1112. (optional)size=1. ...
Lactobacillus reuteri Reduced Bone Loss in Older Women. June 26, 2018 Microbiome Times Pharma & Human Health ... Lactobacillus reuteri ATCC PTA 6475 is a naturally occurring bacteria in the gastrointestinal tract of humans and has been ... The fact that Lactobacillus reuteriATCC PTA 6475 was shown to reduce bone loss in this group is therefore very promising. We ... In the group supplemented by Lactobacillus reuteri the loss in bone density was halved compared to placebo. ...
Lactobacillus reuteri rescuing [mouse] social behaviours: relevance to autism? ... reuteri [Lactobacillus reuteri] was the most drastically reduced (,9-fold) in the MHFD microbiota population, compared to the ... But just before sales of Lactobacillus reuteri increase markedly there is further research to be done. Not least is the ... Lactobacillus reuteri (DSM 17938) in Infants with Functional Chronic Constipation: A Double-Blind, Randomized, Placebo- ...
... on orodispersible lozenges containing a combination of Lactobacillus ... on orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 ... Scientific Opinion on the orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus ... Home / Lactobacillus reuteri: rejection of a health claim on normal gum function ...
Lactobacillus reuteri ADR-1. Probiotics ADR-1, the friendly bacteria that we found from healthy human gut, is able to ...
... and Lactobacillus reuteri. Bacteria which give negative results for the indole test include: Actinobacillus spp., Aeromonas ...
Insufficient evidence for Lactobacillus reuteri and colic, say researchers 08-Oct-2013. By Nathan Gray ... Biogaia are in the news again with two studies that point to the Swedish firms Lactobacillus reuteri Protectis probiotic that ... There is not enough evidence to support use of the probiotic Lactobacillus reuteri to manage colic or prevent crying infants, ... Use of the probiotic Lactobacillus reuteri Protectis could help soothe babies suffering from a common condition known as colic ...
Lactobacillus reuteri is the now and new H pylori cure for ulcers. Search and find out about it. Thanks. ...
Lactobacillus Paracasei: It prevents your teeth and gums from damaging.. *Lactobacillus Reuteri: It restores natural gut flora ...
Lactobacillus Reuteri. Lactobacillus Reuteri is lactic acid and probiotic that helps to repopulate good bacteria which supports ... Lactobacillus paracasei. The ingredient is enriched with probiotics which helps in eliminating sinuses and improving intestinal ...
reuteri SD2112 in pure glycerol solution, purified and used to test the minimal inhibitory (MIC) and minimal bactericidal ... reuteri. Reuterin is active toward enteropathogens, yeasts, fungi, protozoa and viruses, but its effect on commensal intestinal ... Lactobacilli and Clostridium clostridioforme were more resistant with MIC ranging from 15 to 50 mM. No correlation between ... Reuterin produced from glycerol by Lactobacillus reuteri, a normal inhabitant of the human intestine, is a broad-spectrum ...
L Reuteri Lactobacillus. 1 week ago. 2 hours ago. * Natures Cleanse. 1 week ago. 2 hours ago. ...
Lactobacillus GG. Bifidobacterium lactis. Lactobacillus reuteri. Lactobacillus casei. Bifidobacterium bifidum + Streptococcus ...
Lactobacillus rhamnosus GR-1. *Lactobacillus reuteri RC-14. *Lactobacillus acidophilus. *Lactobacillus paracasei ... Lactobacillus. Lactobacillus acidophilus is one of the most common species of bacteria used as a probiotic supplement. ... Lactobacillus acidophilus is a supplement used to help regulate digestion and prevent diarrhea. Side effects of Lactobacillus ... Common side effects of lactobacillus include gas (flatulence) and bloating. Lactobacillus is likely safe when appropriately ...
Lactobacillus rhamnosus. *Lactobacillus reuteri. Each bottle comes with a 30-day supply, and youre instructed to take 1 ...

No FAQ available that match "lactobacillus reuteri"

No images available that match "lactobacillus reuteri"